Document Detail

The Anticancer Ruthenium Complex KP1019 Induces DNA Damage, Leading to Cell Cycle Delay and Cell Death in Saccharomyces cerevisiae.
MedLine Citation:
PMID:  23090979     Owner:  NLM     Status:  Publisher    
The anticancer ruthenium complex trans-[tetrachlorobis(1H-indazole)ruthenate(III)], otherwise known as KP1019, has previously been shown to inhibit proliferation of ovarian tumor cells, induce DNA damage and apoptosis in colon carcinoma cells, and reduce tumor size in animal models. Notably, no dose-limiting toxicity was observed in a Phase I clinical trial. Despite these successes, KP1019's precise mechanism of action remains poorly understood. To determine whether Saccharomyces cerevisiae might serve as an effective model for characterizing the cellular response to KP1019, we first confirmed that this drug is internalized by yeast and induces mutations, cell cycle delay, and cell death. We next examined KP1019 sensitivity of strains defective in DNA repair, ultimately showing that rad1Δ, rev3Δ, and rad52Δ yeast are hypersensitive to KP1019, suggesting that nucleotide excision repair, translesion synthesis, and recombination each play a role in drug tolerance. These data are consistent with published work showing that KP1019 causes interstrand crosslinks and bulky DNA adducts in mammalian cell lines. Published research also showed that mammalian cell lines resistant to other chemotherapeutic agents exhibit only modest resistance, and sometimes hypersensitivity, to KP1019. Here we report similar findings for S. cerevisiae. Whereas gain-of-function mutations in the transcription activator-encoding gene PDR1 are known to increase expression of drug pumps, causing resistance to structurally diverse toxins, we now demonstrate that KP1019 retains its potency against yeast carrying the hypermorphic alleles PDR1-11 or PDR1-3. Combined, these data suggest that S. cerevisiae could serve as an effective model system for identifying evolutionarily conserved modulators of KP1019 sensitivity.
Shannon K Stevens; Amy P Strehle; Rebecca L Miller; Sarah H Gammons; Kyle J Hoffman; John T McCarty; Mary E Miller; Laura K Stultz; Pamela K Hanson
Related Documents :
24044969 - Mart-10, a novel vitamin d analog, inhibits head and neck squamous carcinoma cells grow...
24037599 - Calcifying epithelial odontogenic tumour with clear langerhans cells: a novel variant, ...
23297519 - Antiproliferative effects of selected chemotherapeutics in human ovarian cancer cell li...
20190189 - Gcs-100, a novel galectin-3 antagonist, modulates mcl-1, noxa, and cell cycle to induce...
22708059 - Molecular mechanisms of induced pluripotency.
21307369 - Atfh8 is involved in root development under effect of low-dose latrunculin b in dividin...
23145349 - Live imaging of individual cell divisions in mouse neuroepithelium shows asymmetry in c...
25416509 - Spontaneous encapsulation and concentration of biological macromolecules in liposomes: ...
9874489 - Dendritic cells enhance the differentiation of naïve b cells into plasma cells in vitro.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-22
Journal Detail:
Title:  Molecular pharmacology     Volume:  -     ISSN:  1521-0111     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Birmingham-Southern College;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterization of methicillin-resistant non-Staphylococcus aureus staphylococci carriage isolates ...
Next Document:  The AIDS Pandemic in Historic Perspective.